PPAR - Combination With Metformin

Completed · Phase 3

Conditions studied: Diabetes Mellitus

In brief

A Phase 3, Randomized, Double-blind, Placebo Controlled, Multicenter Trial to Evaluate the Safety and Efficacy of BMS-298585 in Combination with Metformin Therapy in Subjects with Type 2 Diabetes Who Have Inadequate Glycemic Control on Metformin Therapy Alone

Key facts

Study ID
NCT00162240
Run by
Bristol-Myers Squibb
People needed
534
Starts
2003-06-01
Expected to finish
2004-05-01
Last updated by the study team
2012-04-27

Who can join

Age: 18 and older, up to 70. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.